Stocktoria
HENRY SCHEIN INC HSIC
HENRY SCHEIN INC (HSIC) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $13.2B at a 3.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-06 | Barclays | Overweight (main) |
| 2026-08-05 | UBS | Neutral (main) |
| 2026-08-05 | Citigroup | Buy (main) |
| 2026-08-05 | BTIG | Buy (reit) |
| 2026-07-29 | Piper Sandler | Overweight (main) |
| 2026-07-28 | UBS | Neutral (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.11 |
| Retained earnings / assets | 0.294 |
| EBIT / assets | 0.058 |
| Equity / liabilities | 0.607 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| HSIC | HENRY SCHEIN INC | 4/9 | 2.71 | 24.3 | +4% |
| ACH | ACCENDRA HEALTH INC/VA/ | 3/9 | -2.59 | — | +3.1% |
| FZMD | Fuse Medical, Inc. | 4/9 | -0.25 | 0.5 | -8.7% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 32.5 | +14.2% |
| SYY | SYSCO CORP | 5/9 | — | 21.7 | +3.2% |
| PFGC | Performance Food Group Co | 4/9 | 1.92 | 48.3 | +7.2% |
All Wholesale Trade companies →
About HENRY SCHEIN INC
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
FAQ
Is HSIC financially healthy?
HENRY SCHEIN INC's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does HSIC pay a dividend?
No, HENRY SCHEIN INC does not currently pay a dividend.
How profitable is HSIC?
In FY2025, HENRY SCHEIN INC had a net margin of 3.0% and a return on equity of 10.2%.
Is HSIC overvalued or undervalued?
HENRY SCHEIN INC trades at about 27.7× trailing earnings — above its 10-year norm (10-year range 14.8×–26.2×, median 23.1×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for HSIC?
The average Wall-Street price target for HENRY SCHEIN INC is $97.56, about 7.5% above the recent price, from 16 analysts (consensus: buy).
Is HSIC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on HENRY SCHEIN INC: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 24.3×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-27. Facts plus Stocktoria's own computed scores — not investment advice.